MedTrace Logo

Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity

NCT01387074 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2014-02-03

Study results available
· View outcomes & findings →

Summary

This is a prospective, non-interventional, observational study to collect data on the use of botulinum toxin Type A in a routine setting in patients with upper limb adult spasticity.

Conditions

  • Muscle Spasticity

Interventions

BIOLOGICAL

botulinum toxin Type A

Botulinum toxin Type A treatment at a dose determined by the physician at Baseline followed by a second botulinum toxin Type A treatment approximately 12 weeks later if applicable.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01387074 on ClinicalTrials.gov